Two Sigma Investments, LP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $5.46 $49,280 - $2.45 Million	448,002 Added 366.72%	570,168 $62,000
Q3 2022 Nov 14, 2022	BUY	$0.17 - $5.31 $7,751 - $242,130	45,599 Added 59.55%	122,166 $20,000
Q2 2022 Aug 15, 2022	BUY	$0.21 - $0.53 $16,079 - $40,580	76,567 New	76,567 $19,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.11 $62,891 - $116,349	-104,819 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $105,867 - $190,770	104,819 New	104,819 $107,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $282,558 - $1.77 Million	-188,372 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $902,301 - $1.58 Million	188,372 New	188,372 $1.58 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.21B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.